Home / Nervous system / Vigabatrin
ATC N03AG04 · Fatty Acid Derivatives · updated 2 Nov 2026
Vigabatrin shortage
As of 2 Nov 2026, Vigabatrin has a reported shortage in 1 of the 16 countries we track (United States), covering 1 product from 1 company.
Is there a Vigabatrin shortage?
Yes. As of 2 Nov 2026, Vigabatrin is reported short in 1 of the 16 countries we track: United States. No company has given a return date. New since 3 Oct 2026: United States.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Hikma HIK · LSE
Compared with similar medicines
ATC group N03AG · Fatty Acid DerivativesAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Vigabatrin, Tablet, 500 mg (NDC 0054-0652-25) discontinuation | Hikma Pharmaceuticals USA, Inc. | 16 Oct 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Vigabatrin shortage?
Yes. As of 2 Nov 2026, Vigabatrin is reported short in 1 of the 16 countries we track: United States. No company has given a return date. New since 3 Oct 2026: United States.
When will Vigabatrin be back in stock?
No return date has been given; United States: no date given. These are company estimates reported to each authority.
Why is Vigabatrin in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Vigabatrin shortages?
Hikma.